Published in Am J Hum Genet on October 01, 1989
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome. Am J Hum Genet (2005) 1.78
Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. J Clin Invest (1991) 1.65
Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet (2002) 1.55
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J (1991) 1.53
Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (1990) 1.52
Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet (1991) 1.41
Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest (2002) 1.41
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene. Am J Hum Genet (1993) 1.40
In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther (2010) 1.33
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet (1991) 1.30
Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet (1995) 1.23
Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet (1995) 1.15
Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. Am J Hum Genet (1991) 1.13
Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum Gene Ther (2011) 1.13
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet (2009) 1.12
Screening for mutations in the muscle promoter region and for exonic deletions in a series of 115 DMD and BMD patients. J Med Genet (1992) 1.10
Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet (1990) 1.09
Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet (1992) 1.09
The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet (2010) 1.08
Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe. J Clin Invest (1995) 1.01
Predicted and observed sizes of dystrophin in some patients with gene deletions that disrupt the open reading frame. J Med Genet (1992) 0.96
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96
Visualization of individual DNA loops and a map of loop domains in the human dystrophin gene. Nucleic Acids Res (2004) 0.95
Deletions in the 5' region of dystrophin and resulting phenotypes. J Med Genet (1994) 0.90
A TaqI map of the dystrophin gene useful for deletion and carrier status analysis. J Med Genet (1992) 0.89
Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophy. Biomed Res Int (2013) 0.88
Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses. J Virol (2000) 0.85
Evidence of Insulin Resistance and Other Metabolic Alterations in Boys with Duchenne or Becker Muscular Dystrophy. Int J Endocrinol (2015) 0.85
Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications. J Med Genet (1992) 0.81
Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Am J Hum Genet (1993) 0.81
Identification of carriers of Duchenne/Becker muscular dystrophy by a novel method based on detection of junction fragments in the dystrophin gene. J Med Genet (1996) 0.80
Chromosomal rearrangement segregating with adrenoleukodystrophy: a molecular analysis. Proc Natl Acad Sci U S A (1993) 0.79
Duchenne muscular dystrophy (DMD) gene cDNA 8 PstI and TaqI polymorphisms involve exon 51 of the HindIII map. Nucleic Acids Res (1990) 0.78
Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy. J Med Genet (1991) 0.78
Direct analysis of amniotic fluid cells by multiplex PCR provides rapid prenatal diagnosis for Duchenne muscular dystrophy. Nucleic Acids Res (1991) 0.77
A novel splice site mutation in a Becker muscular dystrophy patient. J Med Genet (1996) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75
Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res (1988) 9.94
An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics (1988) 6.51
Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature (1985) 4.62
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Unexpected relationships between four large deletions in the human beta-globin gene cluster. Cell (1983) 3.57
A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics (1988) 2.74
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy. Hum Genet (1987) 2.64
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature (1987) 2.44
A cosmid vector for systematic chromosome walking. Gene (1986) 2.25
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene. Genomics (1988) 2.04
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology (1989) 1.88
Patterns of exon deletions in Duchenne and Becker muscular dystrophy. Hum Genet (1988) 1.73
Deletion of a DNA sequence in eight of nine families with X-linked ichthyosis (steroid sulphatase deficiency). Nucleic Acids Res (1987) 1.62
Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA. Am J Hum Genet (1988) 1.41
Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.17
DNA deletions in mild and severe Becker muscular dystrophy. Hum Genet (1987) 1.14
Molecular deletion analysis in Duchenne muscular dystrophy. J Med Genet (1986) 1.02
Mapping of 12 translocation breakpoints in the Xp21 region with respect to the locus for Duchenne muscular dystrophy. Cytogenet Cell Genet (1988) 0.94
The screening of Duchenne muscular dystrophy patients for submicroscopic deletions. J Med Genet (1986) 0.93
Molecular characterization of a beta zero-thalassemia resulting from a 1.4 kilobase deletion. Blood (1988) 0.88
Microdeletions in patients with X-linked muscular dystrophy: molecular-clinical correlations. Clin Genet (1988) 0.85
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer (1976) 6.48
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet (2000) 5.38
A terminological and ontological analysis of the NCI Thesaurus. Methods Inf Med (2005) 5.11
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
Hair analysis for drugs: technological break-through or ethical quagmire? Addiction (1993) 4.60
DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell (1993) 4.57
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Method for Making Filters Transmitting the Near Ultraviolet and Absorbing Visual Light. Science (1946) 4.01
National asthma attack audit 1991-2. General Practitioners in Asthma Group. BMJ (1993) 3.97
A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature (1988) 3.90
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol (1997) 3.32
Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med (2005) 3.21
Biosynthesis of penicillin N and cephalosporin C. Antibiotic production and other features of the metabolism of Cephalosporium sp. Biochem J (1967) 3.12
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis (2001) 3.11
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Isolation and characterization of a major tandem repeat family from the human X chromosome. Nucleic Acids Res (1983) 2.94
Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol (1996) 2.84
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 2.82
Orbital blowout fractures: a ten-year survey. Plast Reconstr Surg (1967) 2.76
Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature (1993) 2.63
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Acute ileus in myxoedema. Br Med J (1977) 2.57
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol Cell Biol (1986) 2.47
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet (1995) 2.40
When is a deletion not a deletion? When it is converted. Am J Hum Genet (1997) 2.38
Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut (1968) 2.38
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol (2001) 2.31
X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation (1993) 2.30
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology (2001) 2.27
Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
A novel cDNA detects homozygous microdeletions in greater than 50% of type I spinal muscular atrophy patients. Nat Genet (1995) 2.17
Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology (1991) 2.16
Myenteric plexus in Hirschsprung's disease. Gut (1967) 2.11
Marked hypocalcemia and ventricular fibrillation in two pediatric patients exposed to a fluoride-containing wheel cleaner. Ann Emerg Med (1996) 2.11
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Direct observation of one-dimensional diffusion and transcription by Escherichia coli RNA polymerase. Biophys J (1999) 2.09
Laparoscopy in the surgical treatment of rectal cancer in Germany 2000-2009. Colorectal Dis (2012) 2.07
Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil (2001) 2.06
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A (1996) 2.06
21st-century evolution of Greenland outlet glacier velocities. Science (2012) 2.05
Development of a compact fast CCD camera and resonant soft x-ray scattering endstation for time-resolved pump-probe experiments. Rev Sci Instrum (2011) 2.05
Evidence of cadmium toxicity in a population living in a zinc-mining area. Pilot survey of Shipham residents. Lancet (1979) 2.05
Ambulatory blood pressure in pregnancy: comparison of the Spacelabs 90207 and Accutracker II monitors with intraarterial recordings. Am J Obstet Gynecol (1995) 2.03
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
Ocular hypertelorism and pseudohypertelorism. Advances in surgical treatment. Plast Reconstr Surg (1970) 2.01
Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer (1995) 2.00
Observations on the structure, process and clinical outcomes of asthma care in general practice. Br J Gen Pract (1996) 1.94
Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J Pediatr (1993) 1.93
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93
An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy. J Pediatr (1967) 1.92
Basal nitric oxide synthesis in essential hypertension. Lancet (1997) 1.92
Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol (2000) 1.92
Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. J Am Coll Cardiol (1990) 1.91
The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Exp Cell Res (2000) 1.89
Endopeptidase Clp: ATP-dependent Clp protease from Escherichia coli. Methods Enzymol (1994) 1.89
Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology (1989) 1.88
Oral ketamine premedication to alleviate the distress of invasive procedures in pediatric oncology patients. Pediatrics (1992) 1.88
Examinations of chronic pain and affect relationships: applications of a dynamic model of affect. J Consult Clin Psychol (2001) 1.86
Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J Neurosci (1995) 1.85
Genetics of Duchenne muscular dystrophy. Annu Rev Genet (1988) 1.82
Recombination events suggest potential sites for the Huntington's disease gene. Neuron (1989) 1.82
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase. Clin Pharmacol Ther (2015) 1.81
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet (2001) 1.80
Long-term psychosocial outcome in typical absence epilepsy. Sometimes a wolf in sheeps' clothing. Arch Pediatr Adolesc Med (1997) 1.79
Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol (1996) 1.79
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics (1991) 1.77
Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia (1997) 1.77
Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med (1987) 1.74
Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. N Engl J Med (1984) 1.73
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol (1998) 1.72
Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat Genet (1994) 1.70
Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending aorta. Eur J Cardiothorac Surg (2001) 1.69
Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet (1996) 1.69
Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. Hum Mol Genet (1993) 1.67
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem (1995) 1.67
Induction of cellular DNA synthesis by polyoma virus. 3. Induction in productively infected cells. Proc Natl Acad Sci U S A (1966) 1.65
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet (1984) 1.64
Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry (1998) 1.63
The "lazy-T" correction of ectropion of the lower punctum. Arch Ophthalmol (1976) 1.63
Breast reconstruction with myocutaneous flaps in previously irradiated patients. Plast Reconstr Surg (1994) 1.63
Two new proteases in the MHC class I processing pathway. Nat Immunol (2000) 1.63